HTT

uniQure N.V.
uniQure N.V. (QURE)
Price
Market cap
Next catalystMay 1, 2027Ifezuntirgene inilparvovec (AMT-130) — U.S. and European Phase I/II studies · Regulatory decisionCompany release ↗
Cash
Chart & Events
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Ifezuntirgene inilparvovecIfezuntirgene inilparvovec (AMT-130) — U.S. and European Phase I/II studies
HTT
PreINDP1P2P3FilingApproved